US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the...
Read moreWhen the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the...
Read moreVirtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Metals and Mining Virtual Investor...
Read moreThere’s more than one way to invest in copper. In addition to buying shares of copper stocks, investors can gain...
Read moreReviews 2025 exploration strategy across Freegold Mountain and Andalusite Peak Advances acquisition strategy targeting high-grade silver assets Engages Independent Trading...
Read moreExchange-traded funds (ETFs) are one of the fastest-growing investment vehicles, and as uranium’s role in the energy transition grows, investors...
Read moreLegendary investor Warren Buffett is stepping down as CEO of Berkshire Hathaway (NYSE:BRK.A,NYSE:BRK.B) after six decades at the helm —...
Read moreThe US Federal Reserve met on Tuesday (May 6) and Wednesday (May 7) for the third time in 2025. Ultimately,...
Read moreChinese bargain retailer Temu changed its business model in the U.S. as the Trump administration’s new rules on low-value shipments took effect...
Read moreFootwear giant Skechers has agreed to be acquired by private equity firm 3G Capital for $63 per share, ending its nearly three-decade...
Read moreU.S. pharmacy chain Rite Aid on Monday filed for bankruptcy protection for the second time in as many years, according...
Read moreM | T | W | T | F | S | S |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 | 31 |